Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03743246
Title A Study to Evaluate the Safety and Efficacy of JCAR017 in Pediatric Subjects With Relapsed/Refractory (r/r) B-cell Acute Lymphoblastic Leukemia (B-ALL) and B-cell Non-Hodgkin Lymphoma (B-NHL)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Celgene
Indications

B-cell acute lymphoblastic leukemia

Burkitt lymphoma

diffuse large B-cell lymphoma

primary mediastinal B-cell lymphoma

Therapies

Cyclophosphamide + Fludarabine + Lisocabtagene maraleucel

Age Groups: adult | child
Covered Countries USA | ITA | FRA | ESP | DEU | BEL


No variant requirements are available.